USMCA Panel Decision in Mexico - Genetically Modified Corn
The USMCA panel ruled that Mexico's Presidential Corn Decree is inconsistent with multiple provisions of USMCA Chapter 9, primarily because Mexico failed to conduct an adequate risk assessment regarding the use of genetically modified corn in nixtamalized products prior to the Decree’s entry into force.
On December 20, 2024, the USMCA dispute settlement panel issued its highly anticipated final report in the case concerning Mexico’s limitations on genetically modified (GM) corn imports (Mexico – Measures Concerning Genetically Modified Corn, MEX-USA-2023-31-01). This dispute, involving Mexico and the United States, has drawn attention for its implications on agricultural biotechnology, regulatory sovereignty, and the role of free trade agreements in reconciling science-based obligations with domestic policy priorities.
Below, we provide an expert analysis of the panel’s findings, highlight key legal takeaways, and assess the potential compliance scenarios for Mexico and their implications for the global agricultural trade landscape.
The dispute arose from Mexico’s February 2023 Presidential Decree (the “2023 Decree”), which introduced two controversial measures targeting GM corn:
The United States initiated the dispute, arguing that these measures breached Mexico’s obligations under Chapter 9 (Sanitary and Phytosanitary (SPS) Measures) and Chapter 2 (National Treatment and Market Access) of the USMCA, primarily because they were not based on scientific evidence or consistent with international standards.
The panel held that the Article 6.II and Articles 7/8 Measures qualified as SPS measures because they were designed to protect human health and plant life and could affect trade between the USMCA parties. The panel dismissed Mexico’s argument that the measures served non-SPS objectives, emphasizing that the presence of additional goals (e.g., protecting cultural heritage) did not exempt Mexico from its SPS obligations (Panel Report, Mexico – GM Corn, paras. 7.23, 7.156).
Under USMCA Article 9.6.3, SPS measures must be either:
The panel found that Mexico provided neither. Specifically, the evidence Mexico relied upon—such as the 2020 Scientific Dossier and reports in the SNIB Database—did not meet the rigorous standards required of risk assessments. The panel criticized the “haphazard collection of studies” as failing to evaluate risks systematically or in a manner consistent with international guidelines, such as those established by the Codex Alimentarius (Panel Report, paras. 7.89, 7.136).
The Articles 7/8 Measure was criticized for "prejudging" future scientific findings by mandating the substitution of GM corn without completing an adequate risk assessment. The panel dismissed Mexico’s claim that the measure was provisional under USMCA Article 9.6.4(c), citing its lack of time limits and scientific underpinnings (Panel Report, paras. 7.156, 7.215).
The panel acknowledged Mexico’s right to determine its appropriate level of protection (ALOP), including adopting a “zero-risk” standard for GM corn consumption. However, the panel stressed that such a standard must still be based on scientific principles and supported by evidence, noting:
“The main thrust of the SPS chapter is that science must come first. Measures may not be imposed based on theoretical risks or public concerns unsupported by evidence.” (Panel Report, para. 7.234)
The panel emphasized the trade-distorting effects of the measures, particularly the Articles 7/8 Measure, which created uncertainty for U.S. exporters. It stated:
“The measure sends a powerful signal to the market, creating uncertainty for economic operators and undermining the predictability of international trade in GM corn products.” (Panel Report, para. 7.183)
If the panel’s ruling is implemented effectively, the decision will likely:
The Mexico – GM Corn panel decision highlights the tension between a nation’s regulatory autonomy and its international trade commitments. While Mexico sought to prioritize cultural, environmental, and health concerns, the USMCA framework required science-based reasoning and alignment with established trade rules.
For importers, exporters, and policymakers, this case serves as a reminder that regulatory measures impacting trade must be underpinned by robust risk assessments and consistent with international standards. At its core, the ruling reflects a broader principle: trade agreements like the USMCA aim to foster predictability and transparency in regulatory policies while respecting sovereign objectives.
As potential clients or government actors consider their next steps, legal expertise will be critical in navigating compliance pathways, evaluating risk assessment methodologies, and mitigating trade risks. For tailored strategies aligned with your business or policy objectives, contact our firm to discuss how we can assist you in thriving amid evolving trade landscapes.
A copy of the panel report is available here.